\
&
Contact us
\
&
Contact us
The Global Health EDCTP3 Joint Undertaking has published its Work Programme 2026, announcing €147 million to fund research and innovation projects tackling major global health challenges. The 2026 calls for proposals will open mid-January 2026 and include six topics: four research and innovation action (RIA) topics (two-stage) aimed at developing new or improved TB drugs, supporting the prevention and management of lower respiratory tract infections, ensuring better prevention, treatment and management of HIV and its co-infections and co-morbidities, and addressing the global challenge of climate and health. Deadline for short proposals is 4 March 2026 (first stage). Succesful consortia at the first stage will be invited to submit a full proposal by 17 September 2026 (second stage). two coordination and support action (CSA) call topics (single-stage) will support training and capacity-building activities in the areas of ethics, regulatory and pharmacovigilance, and enhance integrated research and healthcare through digital innovation and artificial intelligence. Deadline for submission is 31 August 2026. More information on the Global Health EDCTP3 website. An online Info Day will take place on 5 February 2026. The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) is a partnership between the European Union and the European and Developing Countries Clinical Trials Partnership (EDCTP) Association whose members are several EU Member States and Associated countries and several African countries.
2025-12-05 HealthThe European Rare Diseases Research Alliance (ERDERA) will launch its 2026 joint transnational call 'Resolving unsolved cases in rare genetic and non-genetic diseases' on 10 December 2025. The goal of this call is to solve Undiagnosed Rare Genetic diseases and to address complex, multifactorial Rare Non-Genetic diseases by identifying causative variants in patients with no molecular diagnosis after prior genetic or genomic testing and providing diagnostic clarity for conditions of unknown or mixed pathogenesis.Research Foundation Flanders (FWO) plans to participate in this call. More information on available funding for researchers based in Flanders and on how to apply will be published on FWO's website once the call is launched. Deadline for the submission of pre-proposals is 12 February 2026. Questions on available funding by FWO? Contact europe@fwo.be.More information on the call, its conditions and how to apply will be made available soon on the ERDERA dedicated webpage. Interested in applying? Join the information webinar on 16 December 2025 here.
2025-12-05 HealthOn 10 December, the European Partnership for Personalised Medicine (EP PerMed) will launch its Twinning Call, aiming to accelerate the implementation of personalised medicine (PM) solutions or approaches from one country to another through structured peer-to-peer exchanges.What is Twinning?A Twinning partnership connects a Twinning Donor—an organisation with an innovative PM solution or approach—with a Twinning Receiver seeking to adopt and implement that solution.The call offers up to €50,000 for activities that enable this exchange and strengthen capabilities on both sides. Twinning projects should run for 6 to 12 months.The Twinning Partnerships are aimed in particular at local, regional and national health and care providers legally registered in an EU Member State or a Horizon Europe associated country that wish to adopt PM solutions that are transferable from one provider to another.Currently, an Early Matchmaking phase is underway to help potential Twinning Donors and Receivers connect, share ideas, and start shaping proposals. Join the Matchmaking Platform here (open until 26 February 2026). On 17 December, EP PerMed is organising an info webinar on the upcoming call. Register here.On 15 January, EP PerMed is organising an online Matchmaking event where Twinning Donors and Receiver organisations can present their succesful PM approaches or needs in the form of a pitch. Register here.More information on the Twinning call can be found on the EP PerMed website.
2025-12-02 Horizon Europe Digital Europe EDFRecently, the European Commission has launched 'EU funding & me', a new mobile app aiming to make EU funding simpler, smarter, and closer to people. The app is designed to provide the information of the EU Funding & Tenders portal in a personalised, mobile-friendly format. The new app aims to offer the following services to users: Navigate quickly to EU funding opportunities Check the latest EU funding news and events Save searches, subscribe to topics, and get personalised alerts Receive real-time notifications Integrate seamlessly with tools like calendars and share with one click Check the real-time status of users’ proposals and projects Exchange direct messages between project coordinators and project officers Provide feedback directly to improve the app You can download the app here: EU Funding & Tenders Portal . (Note that it is newly released & some glitches may still occur.)
2025-11-28 Agro-Food, EnvironmentThe new Bioeconomy Strategy outlines a path for building a clean and competitive economy by tapping into renewable resources from land and sea. This strategy not only aims to create jobs but also intends to position Europe as a leader in the transition to clean industries. The bioeconomy currently accounts for a value of up to €2.7 trillion in 2023 and supports approximately 17.1 million jobs in the EU. The strategy outlines the need to scale up innovation and develop lead markets for bio-based materials by encouraging investments in sectors including agriculture, biomanufacturing, and biotechnology. The European Commission will work to create a coherent and simplified regulatory framework that rewards circular and sustainable business models, while safeguarding EU safety standards. Faster, clearer and simpler approvals for innovative solutions will support companies to develop and grow in Europe, especially for SMEs. Interested parties are encouraged to explore the implications of the Bioeconomy Strategy. More information can be found here.
Sign up for personalised information!
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you. By signing up, you can opt in for email notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health AI Continent Deployment: Best use of technologies
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
